Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study

This cohort study assessed the pancreatic safety of vildagliptin versus other noninsulin antidiabetic drugs (NIADs) based on data from five European electronic health care databases. Patients with type 2 diabetes aged ≥18 years on NIAD treatment were enrolled. Adjusted incidence rate ratios (IRRs) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Rachael, Kothny, Wolfgang, Serban, Carmen, Lopez‐Leon, Sandra, Schlienger, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458459/
https://www.ncbi.nlm.nih.gov/pubmed/31008361
http://dx.doi.org/10.1002/edm2.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458459/
https://www.ncbi.nlm.nih.gov/pubmed/31008361
http://dx.doi.org/10.1002/edm2.52

Ejemplares similares